Publications

Antitrypanosomal 8-Hydroxy-Naphthyridines Are Chelators of Divalent Transition Metals.

Wall RJ, Moniz S, Thomas MG, Norval S, Ko E-J, Marco M, et al. Antimicrob Agents Chemother. 2018;62(8):1–15. The lack..

Read More

Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Susan Wyllie, Michael Thomas, Stephen Patterson, Sabrinia Crouch, Manu De Rycker, Rhiannon Lowe, Stephanie Gresham, Michael D. Urbaniak, Thomas D...

Read More

Challenges and recent progress in drug discovery for tropical diseases.

De Rycker M, Baragaña B, Duce SL, Gilbert IH. Nature  559,  498–506 (2018) Infectious tropical diseases have a huge effect in terms of..

Read More

Comparative proteomics of the two T. brucei PABPs suggests that PABP2 controls bulk mRNA.

Zoltner M, Krienitz N, Field MC, Kramer S. PLoS Negl Trop Dis. 2018;12(7). Poly(A)-binding proteins (PABPs) regulate mRNA fate by..

Read More

The mRNA cap methyltransferase gene TbCMT1 is not essential in vitro but is a virulence factor in vivo for bloodstream form Trypanosoma brucei.

Kelner A, Tinti M, Guther MLS, Foth BJ, Chappell L, Berriman M, et al. PLoS One [Internet]. 2018;13(7):e0201263. Messenger RNA..

Read More

Adaptation and Therapeutic Exploitation of the Plasma Membrane of African Trypanosomes.

Quintana JF, Canavate R, Pino D, Yamada K, Zhang N, Field MC. Genes 2018, 9, 368. African trypanosomes are highly..

Read More

Faster growth with shorter antigens can explain a VSG hierarchy during African trypanosome infections: a feint attack by parasites.

Liu D, Albergante L, Newman TJ, Horn D. Sci Rep [Internet]. 2018;8(1). The parasitic African trypanosome, Trypanosoma brucei, evades the..

Read More

Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery.

MacLean LM, Thomas J, Lewis MD, Cotillo I, Gray DW, De Rycker M. PLoS Negl Trop Dis [Internet]. 2018;12(7):e0006612. Chagas’..

Read More

Melarsoprol Resistance in African Trypanosomiasis

Fairlamb Alan H, Horn David Trends Parasitology Volume 34, Issue 6, June 2018, Pages 481-492 Arsenical monotherapies were previously very..

Read More

Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB

Cleghorn LAT, Ray PC, Odingo J, Kumar A, Wescott H, Korkegian A, et al. J Med Chem. 2018;61(15):6592–608. With the..

Read More